Our Principal, Pauli Wong, was invited to be one of the guest speakers at the “GBA Innovative MedTech Development Luncheon” on Wednesday (15 February) at HKSTP, sharing her insights on the unique IP challenges MedTech and healthcare innovations face in the GBA and China. The event was co-hosted by Society for Innovative Healthcare Hong Kong, Hong Kong College of Health Service Executives, GBA Medical Professional Study Tour, Doctors Think Tank Academy and CycloCorp.
我們過去活動
Recommended Insights
CHINA: New Patent Examination Guidelines Now Available for Public Comment
2021年8月4日Two months after the new Chinese Patent law came into effect, the CNIPA has released a new set of Patent Examination Guidelines (proposed version) for public comments on Aug 3, 2021. Here are the explanation of the amendments (Chinese only). Here is the full set of proposed amendments (Chinese only). Briefly, the new amendment focuses […]
閱讀更多 >
The Latest on Post-Filing Data in China’s Patent Law
2020年4月29日Post-filing data can sometimes be the crucial difference between a patent allowance and a final rejection. The reasons are endless why important data may not have been included in the original patent application as filed. Time and budget may have been insufficient to generate data over the full scope of the claims at the time […]
閱讀更多 >
AI, Big Data, and Blockchain - CNIPA seeks public comment on draft patent examination guidelines
2019年11月21日Exciting new changes continue to happen with the Chinese Patent Office (CNIPA). On November 12, 2019, the CNIPA published a new set of amendments to Part II Chapter 9 of the Patent Examination Guidelines (“Draft”) and requested public comment by December 11, 2019. In summary, the new guidelines clarify how emerging technologies involving artificial intelligence, […]
閱讀更多 >
China Hands Down First Batch of Patent Linkage “Paragraph IV” Litigation Results
2022年6月30日China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage. Details of the new implementation measures for patent linkage (technically “early dispute resolution mechanisms for drug patents”) came into effect on July 4, 2021. At around the same time, […]
閱讀更多 >